Technical information
Manufacturer
IDORSIA PHARMACEUTICALS FRANCE SAS
Presentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
Y7n9Nu3y0YNQNH0k
Listen
